BuChE-IN-20
BuChE-IN-20 is a selective butyrylcholinesterase (hBuChE) inhibitor (IC50 = 0.13 μM) with BBB permeability. BuChE-IN-20 is a L-Tryptophan derivative. BuChE-IN-20 possesses neuroprotective properties by inhibiting the production of nitric oxide (NO) and lowering the levels of ROS. BuChE-IN-20 is proficient in inhibiting the self-aggregation of amyloid-beta (Aβ) peptides. BuChE-IN-20 can be used in research for Alzheimer’s disease[1].
Product Specifications
UNSPSC
12352005
Target
Amyloid-β; Cholinesterase (ChE) ; Interleukin Related; NOD-like Receptor (NLR) ; Reactive Oxygen Species (ROS)
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB
Applications
Neuroscience-Neurodegeneration
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
OC1=C(F)C=C(CN[C@@H](CC2=CNC3=CC=CC=C32)C(N(C)CCC4=CNC5=C4C=CC=C5)=O)C=C1
Molecular Formula
C29H29FN4O2
Molecular Weight
484.56
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GRAMD2B (NM_001146320) Human Over-expression Lysate
IGFBPL1 (NM_001007563) Human Over-expression Lysate
![5H-Pyrido[1,2,3-de]-1,4-benzoxazine-D3 Boron Derivative](https://cdn.genprice.uk/products/572/3522617571433/imageurl/trc-p875310-5mg.webp)
5H-Pyrido[1,2,3-de]-1,4-benzoxazine-D3 Boron Derivative
